2-(2-Chloro-acetylamino)-4-(4-methoxy-phenyl)-thiophene-3-carboxylic acid ethyl ester, 95.0%, 250mg

2-(1H-1,2,4-triazol-5-yl)pyrazine, 98.0%, 1g

3-(2-methoxyethyl)-6-(methylsulfonyl)benzo[d]thiazol-2(3H)-imine, 95.0%, 500mg

Ethyl ethanesulfonate, 97%, 5g

N-(Ethylcarbamoyl)-3-(4-((5-formyl-4-methoxy-2-phenyl-1H-imidazol-1-yl)methyl)phenyl)-5-isobutylthiophene-2-sulfonamide, 98%, 5mg

6-(2-(Benzyloxy)ethoxy)hexan-1-ol, 95%, 100mg

4-Chloro-3-hydroxy-5-nitrobenzoic acid, 98%, 1g

2-Bromothiazole>98.0%(GC)25g

Ethyl 3-amino-2,5-dichlorobenzoate, 97%, 1g

Ácido fórmico D solución al 95 % en D2O, 98 % atómico D, 5 ml, envase de vidrio

2-(p-Tolyl)pyridine>97.0%(GC)5g

4-(2-Bromoethyl)benzenesulfonic acid, 97%, 5g

2-Chloro-4H-thieno[3,2-b]pyrrole-5-carboxylic acid, 97%, 5g